373 related articles for article (PubMed ID: 28278336)
41. HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population.
Gonçalo M; Coutinho I; Teixeira V; Gameiro AR; Brites MM; Nunes R; Martinho A
Br J Dermatol; 2013 Sep; 169(3):660-5. PubMed ID: 23600531
[TBL] [Abstract][Full Text] [Related]
42. Investigating the association of Lamotrigine and Phenytoin-induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis with HLA-B*1502 in Iranian population.
Sabourirad S; Mortezaee R; Mojarad M; Eslahi A; Shahrokhi Y; Kiafar B; Jarahi L; Afkhami Ardakani S; Farrokhi S
Exp Dermatol; 2021 Feb; 30(2):284-287. PubMed ID: 33217035
[TBL] [Abstract][Full Text] [Related]
43. Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.
Tangamornsuksan W; Chaiyakunapruk N; Somkrua R; Lohitnavy M; Tassaneeyakul W
JAMA Dermatol; 2013 Sep; 149(9):1025-32. PubMed ID: 23884208
[TBL] [Abstract][Full Text] [Related]
44. Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians.
Chen CB; Hsiao YH; Wu T; Hsih MS; Tassaneeyakul W; Jorns TP; Sukasem C; Hsu CN; Su SC; Chang WC; Hui RC; Chu CY; Chen YJ; Wu CY; Hsu CK; Chiu TM; Sun PL; Lee HE; Yang CY; Kao PH; Yang CH; Ho HC; Lin JY; Chang YC; Chen MJ; Lu CW; Ng CY; Kuo KL; Lin CY; Yang CS; Chen DP; Chang PY; Wu TL; Lin YJ; Weng YC; Kuo TT; Hung SI; Chung WH;
Neurology; 2017 Jan; 88(1):78-86. PubMed ID: 27913699
[TBL] [Abstract][Full Text] [Related]
45. Clinical features of and genetic predisposition to drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a single Korean tertiary institution patients-investigating the relation between the HLA -B*4403 allele and lamotrigine.
Park HJ; Kim SR; Leem DW; Moon IJ; Koh BS; Park KH; Park JW; Lee JH
Eur J Clin Pharmacol; 2015 Jan; 71(1):35-41. PubMed ID: 25327504
[TBL] [Abstract][Full Text] [Related]
46. Specific association of the rs6500265 and rs9933632 single-nucleotide polymorphisms in Japanese patients with antipyretic analgesic-related Stevens-Johnson syndrome and toxic epidermal necrolysis with severe ocular involvements.
Okamoto-Uchida Y; Nakamura R; Matsunaga K; Aihara M; Saito Y
Pharmacogenet Genomics; 2018 Mar; 28(3):95-98. PubMed ID: 29239905
[TBL] [Abstract][Full Text] [Related]
47. Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population.
Tassaneeyakul W; Prabmeechai N; Sukasem C; Kongpan T; Konyoung P; Chumworathayi P; Tiamkao S; Khunarkornsiri U; Kulkantrakorn K; Saksit N; Nakkam N; Satapornpong P; Vannaprasaht S; Sangviroon A; Mahasirimongkol S; Wichukchinda N; Rerkpattanapipat T; Tassaneeyakul W
Pharmacogenet Genomics; 2016 May; 26(5):225-34. PubMed ID: 26928377
[TBL] [Abstract][Full Text] [Related]
48. Genetic predisposition for the development of lamotrigine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis.
Das SK; Sampath A; Zaman SU; Pati AK; Atal S
Per Med; 2023 Mar; 20(2):201-213. PubMed ID: 37194923
[TBL] [Abstract][Full Text] [Related]
49. Findings by an International Collaboration on SJS/TEN With Severe Ocular Complications.
Ueta M
Front Med (Lausanne); 2021; 8():649661. PubMed ID: 34926478
[TBL] [Abstract][Full Text] [Related]
50. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis.
Kaniwa N; Saito Y; Aihara M; Matsunaga K; Tohkin M; Kurose K; Sawada J; Furuya H; Takahashi Y; Muramatsu M; Kinoshita S; Abe M; Ikeda H; Kashiwagi M; Song Y; Ueta M; Sotozono C; Ikezawa Z; Hasegawa R;
Pharmacogenomics; 2008 Nov; 9(11):1617-22. PubMed ID: 19018717
[TBL] [Abstract][Full Text] [Related]
51. Unique motif shared by HLA-B*59:01 and HLA-B*55:02 is associated with methazolamide-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese.
Jiang M; Yang F; Zhang L; Xu D; Jia Y; Cheng Y; Han S; Wang T; Chen Z; Su Y; Zhu Z; Chen S; Zhang J; Wang L; Yang L; Yang J; Luo X; Xing Q
J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):873-880. PubMed ID: 35122707
[TBL] [Abstract][Full Text] [Related]
52. Susceptibility Genes and HLA for Cold Medicine-Related SJS/TEN with SOC.
Ueta M
Front Genet; 2022; 13():912478. PubMed ID: 35899189
[TBL] [Abstract][Full Text] [Related]
53. Increased risk of strontium ranelate-related SJS/TEN is associated with HLA.
Lee HY; Shen MX; Lim YL; Tay YK; Chan MM; Pang SM; Xiao ZW; Ang SB; Ren EC
Osteoporos Int; 2016 Aug; 27(8):2577-83. PubMed ID: 27003892
[TBL] [Abstract][Full Text] [Related]
54. HLA-B*59:01: a marker for Stevens-Johnson syndrome/toxic epidermal necrolysis caused by methazolamide in Han Chinese.
Yang F; Xuan J; Chen J; Zhong H; Luo H; Zhou P; Sun X; He L; Chen S; Cao Z; Luo X; Xing Q
Pharmacogenomics J; 2016 Feb; 16(1):83-7. PubMed ID: 25918017
[TBL] [Abstract][Full Text] [Related]
55. Strong association between HLA-A*0206 and Stevens-Johnson syndrome in the Japanese.
Ueta M; Sotozono C; Tokunaga K; Yabe T; Kinoshita S
Am J Ophthalmol; 2007 Feb; 143(2):367-8. PubMed ID: 17258541
[TBL] [Abstract][Full Text] [Related]
56. Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions.
Kongpan T; Mahasirimongkol S; Konyoung P; Kanjanawart S; Chumworathayi P; Wichukchinda N; Kidkeukarun R; Preechakul S; Khunarkornsiri U; Bamrungram W; Supharatwattanakun B; Mootsikapun P; Kwangsukstid S; Denjanta S; Vannaprasaht S; Rungapiromnan W; Suwankesawong W; Tassaneeyakul W; Tassaneeyakul W
Pharmacogenet Genomics; 2015 Aug; 25(8):402-11. PubMed ID: 26086150
[TBL] [Abstract][Full Text] [Related]
57. A marker for Stevens-Johnson syndrome ...: ethnicity matters.
Lonjou C; Thomas L; Borot N; Ledger N; de Toma C; LeLouet H; Graf E; Schumacher M; Hovnanian A; Mockenhaupt M; Roujeau JC;
Pharmacogenomics J; 2006; 6(4):265-8. PubMed ID: 16415921
[TBL] [Abstract][Full Text] [Related]
58. Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis.
Tangamornsuksan W; Lohitnavy M
Pharmacogenomics J; 2019 Jun; 19(3):286-294. PubMed ID: 30242287
[TBL] [Abstract][Full Text] [Related]
59. The association of HLA B*15:02 allele and Stevens-Johnson syndrome/toxic epidermal necrolysis induced by aromatic anticonvulsant drugs in a South Indian population.
Devi K
Int J Dermatol; 2018 Jan; 57(1):70-73. PubMed ID: 29076187
[TBL] [Abstract][Full Text] [Related]
60. Oxcarbazepine-induced Stevens-Johnson syndrome: a case report.
Lin LC; Lai PC; Yang SF; Yang RC
Kaohsiung J Med Sci; 2009 Feb; 25(2):82-6. PubMed ID: 19321411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
